Published • loading... • Updated
FDA Recalls Dog and Horse Medication over Glass Fiber Material
American Regent said no injuries have been reported and told pet owners to stop using affected lots and return them.
- The FDA announced a nationwide recall of select Adequan Canine Injection and Adequan i.m. Injection lots after manufacturer American Regent Inc. discovered glass fibers in product samples during routine testing.
- American Regent Inc. detected the glass fibers while testing retained samples and stated it is "committed to the safety of patients who rely on its products" while taking this precautionary action to protect public health.
- Affected Adequan Canine lots include 3369 and 25011 , while horse injection lots 24416 and 25265P are also included. Veterinarians administer these medications to treat joint dysfunction.
- Consumers must immediately stop using medication from recalled lots and either dispose of it or return it to American Regent. Pet owners should contact Veterinarians if their animals experience any problems connected to the medication.
- As of July 31, American Regent had received no reports of Adverse events associated with the recalled lots, though injecting particulate matter like glass fibers "may result in local irritation, swelling, inflammation, injection site pain, infection, or abscesses.
Insights by Ground AI
43 Articles
43 Articles
Dog Medication Recalled Nationwide After Glass Fibers Found Inside
American Regent, Inc. Animal Health has issued a nationwide voluntary recall of two lots of Adequan Canine Injection for dogs after glass fibers were found during testing of samples retained by the company. The recall extends to the consumer level. The company announced the recall on July 31, 2026, and …
Coverage Details
Total News Sources43
Leaning Left0Leaning Right0Center42Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
